Activated SRC protein tyrosine kinase is overexpressed in late-stage human ovarian cancers

Gynecol Oncol. 2003 Jan;88(1):73-9. doi: 10.1006/gyno.2002.6851.


Objective: The objective of this study was to determine if the Src tyrosine kinase is overexpressed and activated in late-stage human ovarian cancers.

Methods: Western analysis and immune complex kinase assays were performed on a panel of human ovarian cancer cell lines and normal ovarian epithelial cell cultures, and immunohistochemical analysis for Src and activated Src were performed on a panel of late-stage human ovarian tumors.

Results and conclusions: Src is overexpressed and activated in a majority of late-stage ovarian tumors as well as in a panel of cultured malignant human ovarian epithelium grown in vitro, but not in normal ovarian epithelium (NOE) or immortalized NOE. Src overexpression was found to be frequently, but not always, associated with HER-2/neu overexpression, but no statistical association between Src and Her-2/neu overexpression could be demonstrated.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Enzyme Activation
  • Female
  • HT29 Cells / enzymology
  • Humans
  • Immunohistochemistry
  • Neoplasm Staging
  • Ovarian Neoplasms / enzymology*
  • Ovarian Neoplasms / pathology
  • Proto-Oncogene Proteins c-yes
  • Receptor, ErbB-2 / biosynthesis
  • Tumor Cells, Cultured
  • src-Family Kinases / biosynthesis
  • src-Family Kinases / metabolism*


  • Receptor, ErbB-2
  • Proto-Oncogene Proteins c-yes
  • YES1 protein, human
  • src-Family Kinases